Advertisement

Topics

Phage Biotechnology Corp Company Profile

00:34 EDT 26th September 2018 | BioPortfolio

Phage Biotechnology Corporation (Phage) is a Delaware Corporation, incorporated in 1998 and headquartered in Las Vegas, Nevada. The company has a manufacturing plant in Irvine, California, with research and development laboratories in Kiev, Ukraine. Currently Phage has approximately 75 employees worldwide. The Company was initially formed to manufacture recombinant protein pharmaceuticals as “generic” drugs. This initial focus has been expanded to also include the development of new pegylated forms of existing drugs, as well as single chain antibody pharmaceuticals to treat cancer, arthritis, and auto-immune diseases.
Phage is a biopharmaceutical corporation which manufactures protein pharmaceuticals. The protein pharmaceuticals fall into three main classes, including 1) “bio-similar” versions of marketed drugs whose patents have expired, 2) new drug candidates developed by Phage that will undergo clinical trials, including longer-acting versions of marketed protein products, and 3) a new class of biopharmaceuticals, Single Chain Antibodies, that will compete with monoclonal antibodies for the treatment of cancer, arthritis, and autoimmune diseases. Utilizing a proprietary process, recombinant proteins can be produced with a unique combination of plasmid and bacteriophage technologies. This technology is being applied to the production of key protein pharmaceuticals, with multi-billion dollar estimated market values. Phage plans to manufacture and sell these protein products on a worldwide basis.
As a result of this production advantage, Phage is targeting the production and sale of drugs that no longer have patent protection. It is anticipated that the primary method for developing sales will be to offer buyers of these types of drugs a substantial price discount compared to all other pharmaceutical producers. It is estimated that Phage can discount its sales price for these drugs from between 30% to 50% of the sales price other companies are charging for the identical drugs. Even marketing these drugs at discounted levels will provide Phage with significant profit margins, in large part as a result of the minimal costs associated with manufacturing these drugs utilizing the Phage system. In addition to developing biopharmaceuticals whose patents have expired, Phage is also developing new pegylated versions of these drugs that should substantially increase the marketplace for these drugs. Most protein drugs must be injected, some daily, but pegylated versions of these drugs often go to once-weekly injections due to their much expanded half-life in the body’s circulation.

Location

1635 Village Center CircleSuite 240
Las Vegas
Nevada
89134
United States of America

Contact

Phone: 702/492-6694
Fax: 702/492-9903
Email: jappleman@phagebiotech.com


News Articles [231 Associated News Articles listed on BioPortfolio]

#jobs #lifescience Paramount Recruitment: Phage Display Scientist – Cambridge – 9 months FTC

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Paramount Recruitment: Phage Display Scientist – Cambridge – 9 mo...

First phage therapy center in the U.S. signals growing acceptance

Phage therapy went out of fashion in the U.S. decades ago. Now a new center at the University of California, San Diego wants to revive it to combat antibiotic-resistant infections.

CRISPR-Cas3 Platform Developer Locus Biosciences Acquires EpiBiome Phage Technology

Locus Biosciences, a developer of CRISPR-Cas3-engineered precision antibacterial products, has acquired EpiBiome’s high-throughput bacteriophage phage discovery platform for an undisclosed price, in...

Antibiotic Development Question: Should A Phage Library Equal One Application?

FDA may have to take a personalized medicine approach when deciding how to classify a phage bank used to create...   

Turning a phage

(University of California - San Diego) With microbial resistance to antibiotics growing into a major global health crisis, researchers at University of California San Diego School of Medicine, in coll...

Korea Investment CORP Boosts Stake in Mylan

Korea Investment CORP grew its position in Mylan by 462.1% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 736,474 shar...

Lesaffre invests €15.5m in phage start-up

Engineered Bacteriophage with Dual Tail Fibers that Targets Non-Native Pathogenic Host

Bacteriophage (“Phage”) is a virus that can infect and kill bacteria. Because of this ability, phage is now being considered as an alternative to antibiotics that fail to treat infections caused b...

PubMed Articles [368 Associated PubMed Articles listed on BioPortfolio]

Contemporary Phage Biology: From Classic Models to New Insights.

Bacteriophages, discovered about a century ago, have been pivotal as models for understanding the fundamental principles of molecular biology. While interest in phage biology declined after the phage ...

Isolation and Characterization of a Lytic Bacteriophage (vB_PmiS-TH) and Its Application in Combination with Ampicillin against Planktonic and Biofilm Forms of Proteus mirabilis Isolated from Urinary Tract Infection.

Proteus mirabilis is one of the most common causes of urinary tract infection (UTI), particularly in patients undergoing long-term catheterization. Phage vB_PmiS-TH was isolated from wastewater with h...

Sequencing, genome analysis and host range of a novel Ralstonia phage, RsoP1EGY, isolated in Egypt.

A novel Ralstonia phage was isolated from soil in Egypt. It was designated Ralstonia phage RsoP1EGY using our phage identifier naming approach to reflect the phage's bacterial host species, characteri...

Expert Opinion on Three Phage Therapy Related Topics: Bacterial Phage Resistance, Phage Training and Prophages in Bacterial Production Strains.

Phage therapy is increasingly put forward as a "new" potential tool in the fight against antibiotic resistant infections. During the "Centennial Celebration of Bacteriophage Research" conference in Tb...

Exploiting Bacteriophage Proteomes: The Hidden Biotechnological Potential.

Bacteriophages encode many distinct proteins for the successful infection of a bacterial host. Each protein plays a specific role in the phage replication cycle, from host recognition, through takeove...

Clinical Trials [18 Associated Clinical Trials listed on BioPortfolio]

Evaluation and Detection of Facial Propionibacterium Acnes Bacteria and Phage

This multi-center, outpatient study will extract and evaluate the presence of facial P. acnes bacteria and phage strains using pore strips on up to 400 human subjects.

Ascending Dose Study of the Safety of AB-SA01 When Topically Applied to Intact Skin of Healthy Adults

This study will examine the safety of ascending doses of AB-SA01 when topically applied to intact skin of healthy adults.

A Pilot Scheme - Specimen Collection of Health Management Center

Biomedical and biotechnology industry is internationally regarded as the most brilliant star performer of the future. The development of biomedical depends on a high quality academic resea...

Phage II Trial of Stathmin as Predictive Biomarker for TPF Induction Chemotherapy in OSCC

To investigate the predictive value of stathmin expression as a predictive biomarker in OSCC patients, who treated with TPF (docetaxel, cisplatin and 5-fluorouracil ) induction chemotherap...

Bacteriophages for Treating Urinary Tract Infections in Patients Undergoing Transurethral Resection of the Prostate: A Randomized, Placebo-controlled, Double-blind Clinical Trial

Urinary tract infections are among the most prevalent microbial diseases and their financial burden on society is substantial. The use of bacteriophages against bacterial pathogens has gai...

Companies [954 Associated Companies listed on BioPortfolio]

Phage Biotechnology Corp

Phage Biotechnology Corporation (Phage) is a Delaware Corporation, incorporated in 1998 and headquartered in Las Vegas, Nevada. The company has a manufacturing plant in Irvine, California, with resear...

Vincogen Corporation

Vincogen Corporation is a RF ID Biochip company established in year 2000 and has developed a proprietary radio-frequency (RF) biochip platform and T4 Phage Display platforms for use in several applica...

Special Phage Services

Few inventions in science and medicine have had such a profound effect on human health as the discovery and subsequent development of antibiotics. Following their introduction during World War II ma...

Phage Biotech Ltd.

Phage-Biotech Ltd. was incorporated in March 2000, as a new player in the emerging field of Phage Therapy. The Company’s mission is to develop proprietary Phage-based anti-infective therapeutics to ...

Adaptive Phage Therapeutics, Inc.

More Information about "Phage Biotechnology Corp" on BioPortfolio

We have published hundreds of Phage Biotechnology Corp news stories on BioPortfolio along with dozens of Phage Biotechnology Corp Clinical Trials and PubMed Articles about Phage Biotechnology Corp for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Phage Biotechnology Corp Companies in our database. You can also find out about relevant Phage Biotechnology Corp Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...


Corporate Database Quicklinks



Searches Linking to this Company Record